FindTrial
Sign In

Retrospective analysis of perioperative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), based on a surgical database of the University Hospital Dresden, referring to the years 2013-2020

Retrospective analysis of perioperative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), based on a surgical database of the University Hospital Dresden, referring to the years 2013-2020

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028850
Enrollment
173
Registered
2022-04-15
Start date
2021-02-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C16 C18 C20 C22

Interventions

Group 1: Patients who received cytoreductive surgery and/or HIPEC (regardless of underlying diagnosis) in the UKD (VTG) from 2013-2020.

Sponsors

Universitätsklinikum Carl Gustav Carus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who received cytoreductive surgery and/or HIPEC (regardless of underlying diagnosis) in the UKD (VTG) from 2013-2020 will be included.

Exclusion criteria

Exclusion criteria: does not apply

Design outcomes

Primary

MeasureTime frame
Analysis and presentation of patient characteristics, perioperative and postoperative parameters, and oncological parameters.—

Secondary

MeasureTime frame
-Univariate and multivariate analysis for the identification of risk factors for the occurrence of postoperative morbidity and mortality. - Subgroup analyses with respect to the underlying tumor Tumor disease as well as the HIPEC regimen used.—

Countries

Germany

Contacts

Public ContactCarina Riediger-Schweipert

Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Carl Gustav Carus der TU Dresden

carina.riediger@uniklinikum-dresden.de+49-351-458 18353

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026